Loading...
Loading...
Of the 4 tracked institutions holding AYTU, 2 have a 3-year clone track record — 2 of them beat the S&P. Average holder's clone alpha: +8.4pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 4 tracked institutional investors we monitor, AYTU (AYTU BIOPHARMA INC) is held with a combined value of $1.14M across 431,940 shares. The largest holder is VANGUARD GROUP INC with a position worth $724.32K. 2 funds increased their holdings.
Total Institutional Value
$1.14M
Total Shares Held
431,940
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $724.32K | 0.00% | - |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $255.86K | 0.00% | +4.6% |
| 3 | CITADEL ADVISORS LLC | $100.58K | 0.00% | +136.9% |
| 4 | BlackRock, Inc. | $62.23K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of AYTU with a position worth $724.32K, representing 0.00% of their portfolio. In total, 4 institutional investors hold AYTU with a combined value of $1.14M.
Institutional investors hold $1.14M worth of AYTU stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $724.32K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For AYTU, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their AYTU positions.
Last Close
$2.16
2026-07-24
YTD
-22.0%
38% of 52-week range
